Eyevensys is a private biotechnology company developing a novel approach in the treatment of major ophthalmic diseases. We create a bio therapeutics factory in the eye to allow safe local sustained production of therapeutic proteins, an approach that can address a wide range of ophthalmic diseases. Our approach is based on Eyevensys’ EyeCET platform, the first non-viral technology that allows reprogramming of the ciliary mus...
Eyevensys is a private biotechnology company developing a novel approach in the treatment of major ophthalmic diseases. We create a bio therapeutics factory in the eye to allow safe local sustained production of therapeutic proteins, an approach that can address a wide range of ophthalmic diseases. Our approach is based on Eyevensys’ EyeCET platform, the first non-viral technology that allows reprogramming of the ciliary muscle cells for the production of well-known therapeutic proteins. Eyevensys’ lead product, EYS606 is being developed as a potential new treatment for non-infectious uveitis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.